tiprankstipranks
Biofrontera (BFRI)
NASDAQ:BFRI

Biofrontera Stock Analysis & Ratings

BFRI Stock Chart & Stats

Day’s Range$2.65 - $3.1199
52-Week Range$2.20 - $14.63
Previous Close$2.85
Volume782.61K
Average Volume (3M)2.53M
Market Cap$47.38M
P/E Ratio-1.0
Beta2.98
Next EarningsNov 29, 2022
EPS ForecastN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score5
EPS (TTM)-2.85


Biofrontera News

Currently, no data available
Please return soon. This page is being updated.

---

Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

BFRI FAQ

What was Biofrontera’s price range in the past 12 months?
Biofrontera lowest stock price was $2.20 and its highest was $14.63 in the past 12 months.
    What is Biofrontera’s market cap?
    Biofrontera’s market cap is $47.38M.
      What is Biofrontera’s price target?
      Currently, no data Available
      What do analysts say about Biofrontera?
      Not enough analysts have published a price target to provide an average price target.
      When is Biofrontera’s upcoming earnings report date?
      Biofrontera’s upcoming earnings report date is Nov 29, 2022 which is in 197 days.
        How were Biofrontera’s earnings last quarter?
        Currently, no data Available
        Is Biofrontera overvalued?
        According to Wall Street analysts Biofrontera’s price is currently Overvalued.
          Does Biofrontera pay dividends?
          Biofrontera does not currently pay dividends.
          What is Biofrontera’s EPS estimate?
          Biofrontera’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Biofrontera have?
          Biofrontera has 17,100,000 shares outstanding.
            What happened to Biofrontera’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Biofrontera?
            Currently, no hedge funds are holding shares in BFRI

            ---

            Biofrontera Stock Analysis

            Smart Score
            5
            Neutral
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10
            Price Target
            No data currently available
            The Biofrontera stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
            Learn more about TipRanks Smart Score

            Company Description

            Biofrontera

            Biofrontera Inc is a biopharmaceutical company specializing in the commercialization of pharmaceutical products for the treatment of dermatological conditions, diseases caused by exposure to sunlight that result in sun damage to the skin. Its licensed products focus on the treatment of actinic keratoses, which are skin lesions that can sometimes lead to skin cancer. It also markets a topical antibiotic for the treatment of impetigo, a bacterial skin infection.

            ---
            Similar Stocks
            No data currently available

            Popular Stocks

            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis